{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,17]],"date-time":"2026-03-17T22:28:42Z","timestamp":1773786522249,"version":"3.50.1"},"reference-count":157,"publisher":"Wiley","issue":"3","license":[{"start":{"date-parts":[[2007,12,10]],"date-time":"2007-12-10T00:00:00Z","timestamp":1197244800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["European J of Haematology"],"published-print":{"date-parts":[[2008,3]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Adult T\u2010cell leukemia\/lymphoma (ATLL) is a peripheral T\u2010cell malignancy caused by human T\u2010cell lymphotrophic virus type I. Clinical manifestations of ATLL range from smoldering to chronic, lymphoma and acute. Patients with acute and lymphoma type ATLL require therapeutic intervention. Conventional chemotherapeutic regimens used against other malignant lymphoma have been administered to ATLL patients, but the therapeutic outcomes of acute and lymphoma type ATLL remain very poor. Promising results of allogeneic stem cell transplantation (SCT) for ATLL patients have recently been reported and the treatment outcome might be improved for some ATLL patients. Besides conventional chemotherapy and SCT, interferon, zidovudine, arsenic trioxide, targeted therapy against surface molecule on ATLL cells, retinoid derivatives, and bortezomib have been administered to ATLL patients in pilot or phase I\/II studies. Further studies are required to confirm the clinical benefits of these novel therapeutics. This article reviews the current status and future directions of ATLL treatment.<\/jats:p>","DOI":"10.1111\/j.1600-0609.2007.01016.x","type":"journal-article","created":{"date-parts":[[2008,2,13]],"date-time":"2008-02-13T09:21:34Z","timestamp":1202894494000},"page":"185-196","source":"Crossref","is-referenced-by-count":66,"title":["Treatment of adult T\u2010cell leukemia\/lymphoma: past, present, and future"],"prefix":"10.1111","volume":"80","author":[{"given":"Kenji","family":"Ishitsuka","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kazuo","family":"Tamura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2007,12,10]]},"reference":[{"key":"e_1_2_8_2_2","first-page":"416","article-title":"[Surface markers of malignant lymphoid cells in the classification of lymphoproliferative disorders, with special reference to adult T\u2010cell leukemia (author\u2019s transl)]","volume":"17","author":"Takatsuki K","year":"1976","journal-title":"Rinsho Ketsueki"},{"key":"e_1_2_8_3_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V50.3.481.481"},{"key":"e_1_2_8_4_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.77.12.7415"},{"key":"e_1_2_8_5_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.78.10.6476"},{"key":"e_1_2_8_6_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(85)92734-5"},{"key":"e_1_2_8_7_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.96.7.3848"},{"key":"e_1_2_8_8_2","doi-asserted-by":"publisher","DOI":"10.1038\/348245a0"},{"key":"e_1_2_8_9_2","doi-asserted-by":"publisher","DOI":"10.1089\/088922201300343735"},{"key":"e_1_2_8_10_2","doi-asserted-by":"publisher","DOI":"10.1038\/sj.onc.1208970"},{"key":"e_1_2_8_11_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0042-6822(02)00091-0"},{"key":"e_1_2_8_12_2","first-page":"33","volume-title":"Human T\u2010cell Lymphotropic Virus Type 1","author":"Gessain A","year":"1996"},{"key":"e_1_2_8_13_2","doi-asserted-by":"publisher","DOI":"10.1002\/1097-0142(19890915)64:6<1290::AID-CNCR2820640620>3.0.CO;2-Z"},{"key":"e_1_2_8_14_2","first-page":"478","article-title":"[Registration of hematological disorders by the Kyushu Hematology Organization for Treatment (K\u2010HOT) Study Group]","volume":"45","author":"Kawano R","year":"2004","journal-title":"Rinsho Ketsueki"},{"key":"e_1_2_8_15_2","volume-title":"Epidemiology of HTLV\u2010I\/II in Japan and the World","author":"Tajima K","year":"1992"},{"issue":"3","key":"e_1_2_8_16_2","first-page":"57","article-title":"Primary prevention of HTLV\u20101 in Japan","volume":"11","author":"Hino S","year":"1997","journal-title":"Leukemia"},{"key":"e_1_2_8_17_2","doi-asserted-by":"publisher","DOI":"10.1093\/jnci\/87.13.1009"},{"key":"e_1_2_8_18_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2141.1991.tb08051.x"},{"key":"e_1_2_8_19_2","first-page":"221","volume-title":"Adult T\u2010Cell Leukemia","author":"Shimoyama M","year":"1994"},{"key":"e_1_2_8_20_2","doi-asserted-by":"publisher","DOI":"10.1002\/jmv.1890230205"},{"key":"e_1_2_8_21_2","doi-asserted-by":"publisher","DOI":"10.11150\/kansenshogakuzasshi1970.66.1444"},{"key":"e_1_2_8_22_2","doi-asserted-by":"publisher","DOI":"10.2169\/internalmedicine.31.1132"},{"key":"e_1_2_8_23_2","doi-asserted-by":"crossref","first-page":"2065","DOI":"10.1182\/blood.V76.10.2065.2065","article-title":"Expression of P\u2010glycoprotein in adult T\u2010cell leukemia cells","volume":"76","author":"Kuwazuru Y","year":"1990","journal-title":"Blood"},{"key":"e_1_2_8_24_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V98.4.1160"},{"key":"e_1_2_8_25_2","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1182\/blood.V96.1.275.013k43_275_281","article-title":"Bcl\u2010X(L) is up\u2010regulated by HTLV\u2010I and HTLV\u2010II in vitro and in ex vivo ATLL samples","volume":"96","author":"Nicot C","year":"2000","journal-title":"Blood"},{"key":"e_1_2_8_26_2","doi-asserted-by":"publisher","DOI":"10.1023\/A:1011158021749"},{"key":"e_1_2_8_27_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.94.25.13897"},{"key":"e_1_2_8_28_2","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.00739-06"},{"key":"e_1_2_8_29_2","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1200\/JCO.1988.6.1.128","article-title":"Chemotherapeutic results and prognostic factors of patients with advanced non\u2010Hodgkin\u2019s lymphoma treated with VEPA or VEPA\u2010M","volume":"6","author":"Shimoyama M","year":"1988","journal-title":"J Clin Oncol"},{"key":"e_1_2_8_30_2","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.1988.6.7.1088"},{"key":"e_1_2_8_31_2","first-page":"378a","article-title":"Japan Clinical Oncology Group trial of second\u2010generation \u201cLSG4 protocol\u201d in aggressive lymphoma including ATL: prognostic factors and a predictive model","volume":"13","author":"Tobinai K","year":"1994","journal-title":"Proc Am Soc Clin Oncol"},{"key":"e_1_2_8_32_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF02983215"},{"key":"e_1_2_8_33_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2141.2001.02737.x"},{"key":"e_1_2_8_34_2","doi-asserted-by":"publisher","DOI":"10.1200\/JCO-2007-11-9958"},{"key":"e_1_2_8_35_2","doi-asserted-by":"publisher","DOI":"10.1097\/00042560-199606010-00012"},{"key":"e_1_2_8_36_2","doi-asserted-by":"publisher","DOI":"10.3109\/10428199809068577"},{"key":"e_1_2_8_37_2","doi-asserted-by":"publisher","DOI":"10.3109\/10428199909145950"},{"key":"e_1_2_8_38_2","doi-asserted-by":"publisher","DOI":"10.1002\/1097-0142(19931215)72:12<3614::AID-CNCR2820721211>3.0.CO;2-E"},{"key":"e_1_2_8_39_2","first-page":"1387","article-title":"[Successful chronic daily administration of oral etoposide for a case of adult T cell leukemia]","volume":"20","author":"Matsuoka H","year":"1993","journal-title":"Gan To Kagaku Ryoho"},{"key":"e_1_2_8_40_2","first-page":"839","article-title":"[Oral administration of low\u2010dose etoposide for maintenance chemotherapy in adult T cell leukemia patients]","volume":"21","author":"Utsunomiya A","year":"1994","journal-title":"Gan To Kagaku Ryoho"},{"key":"e_1_2_8_41_2","first-page":"547","article-title":"[Two cases of adult T\u2010cell leukemia . lymphoma (ATL) with long\u2010term remission by chronic daily administration of low\u2010dose etoposide]","volume":"22","author":"Ezoe A","year":"1995","journal-title":"Gan To Kagaku Ryoho"},{"key":"e_1_2_8_42_2","first-page":"1269","article-title":"[Low\u2010dose etoposide in a patient with adult T\u2010cell leukemia\/lymphoma who had severe complications]","volume":"28","author":"Xinjia F","year":"2001","journal-title":"Gan To Kagaku Ryoho"},{"key":"e_1_2_8_43_2","doi-asserted-by":"publisher","DOI":"10.1002\/1097-0142(19930401)71:7<2217::AID-CNCR2820710709>3.0.CO;2-8"},{"key":"e_1_2_8_44_2","first-page":"164","article-title":"Phase I study of YK\u2010176 (2\u2032\u2010deoxycoformycin) in patients with adult T\u2010cell leukemia\u2010lymphoma. The DCF Study Group","volume":"22","author":"Tobinai K","year":"1992","journal-title":"Jpn J Clin Oncol"},{"key":"e_1_2_8_45_2","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.1994.12.12.2588"},{"key":"e_1_2_8_46_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF02986621"},{"key":"e_1_2_8_47_2","doi-asserted-by":"publisher","DOI":"10.1038\/bjc.1994.394"},{"key":"e_1_2_8_48_2","doi-asserted-by":"publisher","DOI":"10.1002\/1097-0142(19900115)65:2<327::AID-CNCR2820650224>3.0.CO;2-W"},{"key":"e_1_2_8_49_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2141.2005.05629.x"},{"key":"e_1_2_8_50_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V93.1.278"},{"key":"e_1_2_8_51_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V98.13.3762"},{"key":"e_1_2_8_52_2","first-page":"1572","article-title":"[Successful treatment of adult T\u2010cell leukemia with interferon\u2010alpha\u20102b by systemic and local administration]","volume":"31","author":"Tanabe Y","year":"1990","journal-title":"Rinsho Ketsueki"},{"key":"e_1_2_8_53_2","first-page":"497","article-title":"[Effect of topical injections of native alpha\u2010interferon (HLBI) in the treatment of skin lesions of adult T cell leukemia: report of a case]","volume":"31","author":"Sugie Y","year":"1990","journal-title":"Rinsho Ketsueki"},{"key":"e_1_2_8_54_2","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-109-12-992_1"},{"key":"e_1_2_8_55_2","first-page":"1476","article-title":"[Successful treatment of an adult T\u2010cell leukemia with alpha\u2010interferon]","volume":"29","author":"Fujimoto T","year":"1988","journal-title":"Rinsho Ketsueki"},{"key":"e_1_2_8_56_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0609.1987.tb00771.x"},{"key":"e_1_2_8_57_2","doi-asserted-by":"publisher","DOI":"10.1002\/1097-0142(19870315)59:6<1059::AID-CNCR2820590602>3.0.CO;2-M"},{"key":"e_1_2_8_58_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2133.1993.tb03347.x"},{"key":"e_1_2_8_59_2","doi-asserted-by":"publisher","DOI":"10.1159\/000058317"},{"key":"e_1_2_8_60_2","first-page":"2975","article-title":"[Clinical study on the effect of natural alpha\u2010interferon (HLBI) in the treatment of adult T\u2010cell leukemia]","volume":"15","author":"Ichimaru M","year":"1988","journal-title":"Gan To Kagaku Ryoho"},{"key":"e_1_2_8_61_2","doi-asserted-by":"publisher","DOI":"10.2169\/internalmedicine.46.6319"},{"key":"e_1_2_8_62_2","doi-asserted-by":"publisher","DOI":"10.1016\/0165-5728(95)00101-7"},{"key":"e_1_2_8_63_2","doi-asserted-by":"publisher","DOI":"10.1086\/380101"},{"key":"e_1_2_8_64_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jneuroim.2004.02.007"},{"key":"e_1_2_8_65_2","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bmt.1701533"},{"key":"e_1_2_8_66_2","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bmt.1702731"},{"key":"e_1_2_8_67_2","doi-asserted-by":"publisher","DOI":"10.1038\/sj.leu.2403682"},{"key":"e_1_2_8_68_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1349-7006.1990.tb02662.x"},{"key":"e_1_2_8_69_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMc053295"},{"key":"e_1_2_8_70_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbmt.2006.09.002"},{"key":"e_1_2_8_71_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2004-11-4193"},{"key":"e_1_2_8_72_2","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(04)01608-0"},{"key":"e_1_2_8_73_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199506293322603"},{"key":"e_1_2_8_74_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199506293322604"},{"key":"e_1_2_8_75_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2141.2001.02794.x"},{"key":"e_1_2_8_76_2","doi-asserted-by":"publisher","DOI":"10.1038\/sj.thj.6200195"},{"key":"e_1_2_8_77_2","doi-asserted-by":"publisher","DOI":"10.3109\/10428190109057927"},{"key":"e_1_2_8_78_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.83.21.8333"},{"key":"e_1_2_8_79_2","doi-asserted-by":"crossref","first-page":"21459","DOI":"10.1016\/S0021-9258(19)36631-1","article-title":"Human DNA polymerases alpha and beta are able to incorporate anti\u2010HIV deoxynucleotides into DNA","volume":"267","author":"Copeland WC","year":"1992","journal-title":"J Biol Chem"},{"key":"e_1_2_8_80_2","doi-asserted-by":"publisher","DOI":"10.1038\/sj.leu.2401742"},{"key":"e_1_2_8_81_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0145-2126(98)00170-2"},{"key":"e_1_2_8_82_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2003-12-4251"},{"key":"e_1_2_8_83_2","doi-asserted-by":"publisher","DOI":"10.1080\/10428190400018349"},{"key":"e_1_2_8_84_2","doi-asserted-by":"publisher","DOI":"10.1007\/s10549-005-5156-0"},{"key":"e_1_2_8_85_2","doi-asserted-by":"publisher","DOI":"10.1128\/MCB.16.1.53"},{"key":"e_1_2_8_86_2","first-page":"579","article-title":"Simultaneous targeting of telomeres and telomerase as a cancer therapeutic approach","volume":"63","author":"Mo Y","year":"2003","journal-title":"Cancer Res"},{"key":"e_1_2_8_87_2","doi-asserted-by":"publisher","DOI":"10.1359\/JBMR.041123"},{"key":"e_1_2_8_88_2","doi-asserted-by":"publisher","DOI":"10.1245\/ASO.2003.03.032"},{"key":"e_1_2_8_89_2","first-page":"173","article-title":"Overexpression of mutated MRP4 in cisplatin resistant small cell lung cancer cell line: collateral sensitivity to azidothymidine","volume":"23","author":"Savaraj N","year":"2003","journal-title":"Int J Oncol"},{"key":"e_1_2_8_90_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2006-01-0067"},{"key":"e_1_2_8_91_2","doi-asserted-by":"publisher","DOI":"10.1038\/sj.onc.1210718"},{"key":"e_1_2_8_92_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.canlet.2005.03.039"},{"key":"e_1_2_8_93_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(05)65260-9"},{"key":"e_1_2_8_94_2","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1182\/blood.V89.2.419","article-title":"3\u2032\u2010Azido 3\u2032\u2010deoxythymidine + methotrexate as a novel antineoplastic combination in the treatment of human immunodeficiency virus\u2010related non\u2010Hodgkin\u2019s lymphomas","volume":"89","author":"Tosi P","year":"1997","journal-title":"Blood"},{"key":"e_1_2_8_95_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2133.1989.tb01361.x"},{"key":"e_1_2_8_96_2","doi-asserted-by":"publisher","DOI":"10.1002\/(SICI)1096-8652(199803)57:3<266::AID-AJH25>3.0.CO;2-7"},{"key":"e_1_2_8_97_2","first-page":"965","article-title":"Experimental treatment of Epstein\u2010Barr virus\u2010associated primary central nervous system lymphoma","volume":"63","author":"Roychowdhury S","year":"2003","journal-title":"Cancer Res"},{"key":"e_1_2_8_98_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2004-09-3748"},{"key":"e_1_2_8_99_2","doi-asserted-by":"publisher","DOI":"10.1172\/JCI113085"},{"issue":"5","key":"e_1_2_8_100_2","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1099\/0022-1317-78-5-1007","article-title":"AZT inhibits the transmission of human T cell leukaemia\/lymphoma virus type I to adult peripheral blood mononuclear cells in vitro","volume":"78","author":"Macchi B","year":"1997","journal-title":"J Gen Virol"},{"key":"e_1_2_8_101_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.46.9.3080-3083.2002"},{"key":"e_1_2_8_102_2","doi-asserted-by":"publisher","DOI":"10.1086\/322785"},{"key":"e_1_2_8_103_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0168-1702(01)00287-8"},{"key":"e_1_2_8_104_2","doi-asserted-by":"publisher","DOI":"10.1186\/1742-4690-3-63"},{"key":"e_1_2_8_105_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0268-960X(02)00075-9"},{"key":"e_1_2_8_106_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2141.1998.01068.x"},{"key":"e_1_2_8_107_2","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1080\/10428190290021461","article-title":"Arsenic trioxide induces apoptosis in HTLV\u2010I infected T\u2010cell lines and fresh adult T\u2010cell leukemia cells through CD95 or tumor necrosis factor alpha receptor independent caspase activation","volume":"43","author":"Ishitsuka K","year":"2002","journal-title":"Leuk Lymphoma"},{"key":"e_1_2_8_108_2","first-page":"2849","article-title":"Arsenic\u2010interferon\u2010alpha\u2010triggered apoptosis in HTLV\u2010I transformed cells is associated with tax down\u2010regulation and reversal of NF\u2010kappa B activation","volume":"96","author":"El\u2010Sabban ME","year":"2000","journal-title":"Blood"},{"key":"e_1_2_8_109_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2002-09-2986"},{"key":"e_1_2_8_110_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2006-04-015537"},{"key":"e_1_2_8_111_2","doi-asserted-by":"publisher","DOI":"10.1038\/sj.thj.6200374"},{"key":"e_1_2_8_112_2","doi-asserted-by":"publisher","DOI":"10.3324\/haematol.10703"},{"key":"e_1_2_8_113_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V82.6.1701.1701"},{"key":"e_1_2_8_114_2","doi-asserted-by":"publisher","DOI":"10.1002\/jcb.240460405"},{"key":"e_1_2_8_115_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V86.11.4063.bloodjournal86114063"},{"key":"e_1_2_8_116_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2133.2006.07355.x"},{"key":"e_1_2_8_117_2","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2000.18.8.1622"},{"key":"e_1_2_8_118_2","doi-asserted-by":"publisher","DOI":"10.3816\/CLM.2003.n.027"},{"key":"e_1_2_8_119_2","doi-asserted-by":"crossref","first-page":"174s","DOI":"10.1200\/jco.2005.23.16_suppl.2533","article-title":"Phase I trial of siplizumab in CD2\u2010positive lymphoproliferative disease","volume":"23","author":"Janik JE","year":"2005","journal-title":"J Clin Oncol"},{"key":"e_1_2_8_120_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2005-01-0335"},{"key":"e_1_2_8_121_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.leukres.2005.05.008"},{"key":"e_1_2_8_122_2","doi-asserted-by":"crossref","first-page":"937a","DOI":"10.1182\/blood.V106.11.3354.3354","article-title":"HuMax\u2010CD4 (Zanolimumab), a fully human monoclonal antibody: early results of an ongoing clinical trial in CD4(+) peripheral T\u2010cell lymphoma of non\u2010cutaneous type","volume":"106","author":"D\u2019Amore F","year":"2005","journal-title":"Blood"},{"key":"e_1_2_8_123_2","doi-asserted-by":"publisher","DOI":"10.1038\/sj.leu.2404958"},{"key":"e_1_2_8_124_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V99.5.1505"},{"key":"e_1_2_8_125_2","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-04-0983"},{"key":"e_1_2_8_126_2","doi-asserted-by":"publisher","DOI":"10.2169\/internalmedicine.35.180"},{"key":"e_1_2_8_127_2","first-page":"4916","article-title":"Role of intracellular redox status in apoptosis induction of human T\u2010cell leukemia virus type I\u2010infected lymphocytes by 13\u2010cis\u2010retinoic acid","volume":"57","author":"Furuke K","year":"1997","journal-title":"Cancer Res"},{"key":"e_1_2_8_128_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0145-2126(98)00049-6"},{"key":"e_1_2_8_129_2","doi-asserted-by":"publisher","DOI":"10.1158\/1535-7163.MCT-05-0434"},{"key":"e_1_2_8_130_2","doi-asserted-by":"publisher","DOI":"10.1038\/sj.leu.2404472"},{"key":"e_1_2_8_131_2","first-page":"1797","article-title":"Concomitant complete remission of APL and smoldering ATL following ATRA therapy in a patient with the two diseases simultaneously","volume":"9","author":"Tsukasaki K","year":"1995","journal-title":"Leukemia"},{"key":"e_1_2_8_132_2","doi-asserted-by":"publisher","DOI":"10.1038\/sj.leu.2403356"},{"key":"e_1_2_8_133_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2133.2005.06974.x"},{"key":"e_1_2_8_134_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0145-2126(00)00126-0"},{"key":"e_1_2_8_135_2","doi-asserted-by":"publisher","DOI":"10.1038\/sj.thj.6200098"},{"key":"e_1_2_8_136_2","doi-asserted-by":"publisher","DOI":"10.1001\/archderm.141.3.301"},{"key":"e_1_2_8_137_2","doi-asserted-by":"publisher","DOI":"10.1126\/science.2843985"},{"key":"e_1_2_8_138_2","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1128\/jvi.69.1.564-569.1995","article-title":"Constitutive phosphorylation and turnover of I kappa B alpha in human T\u2010cell leukemia virus type I\u2010infected and Tax\u2010expressing T cells","volume":"69","author":"Lacoste J","year":"1995","journal-title":"J Virol"},{"key":"e_1_2_8_139_2","first-page":"2360","article-title":"Constitutive activation of NF\u2010kappaB in primary adult T\u2010cell leukemia cells","volume":"93","author":"Mori N","year":"1999","journal-title":"Blood"},{"key":"e_1_2_8_140_2","first-page":"1083","article-title":"Proteasome inhibitor PS\u2010341, a potential therapeutic agent for adult T\u2010cell leukemia","volume":"62","author":"Tan C","year":"2002","journal-title":"Cancer Res"},{"key":"e_1_2_8_141_2","doi-asserted-by":"publisher","DOI":"10.1038\/sj.onc.1208212"},{"key":"e_1_2_8_142_2","doi-asserted-by":"publisher","DOI":"10.1038\/sj.leu.2403400"},{"key":"e_1_2_8_143_2","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bjc.6604003"},{"key":"e_1_2_8_144_2","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2005.04.6789"},{"key":"e_1_2_8_145_2","doi-asserted-by":"publisher","DOI":"10.1002\/1097-0142(19850515)55:10<2491::AID-CNCR2820551030>3.0.CO;2-I"},{"key":"e_1_2_8_146_2","first-page":"135","article-title":"[A patient with marked immunodeficiency in an HTLV\u2010I carrier: a case report]","volume":"40","author":"Iroi A","year":"2000","journal-title":"Rinsho Shinkeigaku"},{"key":"e_1_2_8_147_2","first-page":"822","article-title":"[A HTLV\u2010I carrier initially treated for Pneumocystis carinii pneumonia]","volume":"40","author":"Itoh T","year":"2002","journal-title":"Nihon Kokyuki Gakkai Zasshi"},{"key":"e_1_2_8_148_2","first-page":"317","article-title":"[Pneumocystis carinii pneumonia in a HTLV\u2010I carrier with monoclonal proliferation of HTLV\u2010I infected lymphocyte]","volume":"37","author":"Kawahigashi N","year":"1996","journal-title":"Rinsho Ketsueki"},{"key":"e_1_2_8_149_2","first-page":"2132","article-title":"[Pneumocystis carinii pneumonia in a HTLV\u2010I carrier terminating with acute type of adult T\u2010cell leukemia]","volume":"29","author":"Kuwazuru Y","year":"1988","journal-title":"Rinsho Ketsueki"},{"key":"e_1_2_8_150_2","first-page":"363","article-title":"Immunodeficiency in preclinical smoldering adult T\u2010cell leukemia","volume":"18","author":"Moriyama K","year":"1988","journal-title":"Jpn J Clin Oncol"},{"key":"e_1_2_8_151_2","first-page":"756","article-title":"[Pulmonary complications in patients with adult T\u2010cell leukemia]","volume":"30","author":"Tashiro T","year":"1992","journal-title":"Nihon Kyobu Shikkan Gakkai Zasshi"},{"key":"e_1_2_8_152_2","first-page":"483","article-title":"[Infection control for the treatment of hematological malignancies: a survey of the Kyushu Hematology Organization for Treatment Study Group (K\u2010HOT)]","volume":"44","author":"Ishitsuka K","year":"2003","journal-title":"Rinsho Ketsueki"},{"key":"e_1_2_8_153_2","doi-asserted-by":"publisher","DOI":"10.1210\/jc.79.5.1322"},{"key":"e_1_2_8_154_2","doi-asserted-by":"publisher","DOI":"10.1016\/0006-291X(88)90265-3"},{"key":"e_1_2_8_155_2","doi-asserted-by":"publisher","DOI":"10.1084\/jem.172.3.759"},{"key":"e_1_2_8_156_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V99.2.634"},{"key":"e_1_2_8_157_2","doi-asserted-by":"publisher","DOI":"10.1359\/JBMR.040314"},{"key":"e_1_2_8_158_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMcp042806"}],"container-title":["European Journal of Haematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1600-0609.2007.01016.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1600-0609.2007.01016.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,10]],"date-time":"2023-10-10T19:21:18Z","timestamp":1696965678000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1600-0609.2007.01016.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,12,10]]},"references-count":157,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2008,3]]}},"alternative-id":["10.1111\/j.1600-0609.2007.01016.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1600-0609.2007.01016.x","archive":["Portico"],"relation":{},"ISSN":["0902-4441","1600-0609"],"issn-type":[{"value":"0902-4441","type":"print"},{"value":"1600-0609","type":"electronic"}],"subject":[],"published":{"date-parts":[[2007,12,10]]}}}